LCTC - Lifeloc Technologies:
2,454,116 Shares Outstanding
Lifeloc's current float stands at 192,580 according to my calculations
Total assets $8,028,098
CASH, END OF PERIOD $3,383,541
No toxic financing – Zero
No dilution or reason for dilution - Zero
LCTC's float is in the 20 lowest floats of all U.S. based companies that trade on all exchanges!
It would only take $3 Million to lock up the float at these price levels (192,580 shares in float x current price $15)
As marijuana legalization spreads across the country and the world, the need to get rapid and reliable testing methods to law enforcement officers will only increase. Providing this technology is consistent with Lifeloc’s corporate mission to make our roads and workplaces safer
Marijuana breathalyzer completion date of August 31, 2017 according to latest annual report.
Thanks in part to a $250,000 grant from the Colorado Office of Economic Development, Lifeloc scientists have come up with a method that can not only detect the presence of Delta 9 THC in a person's exhaled breath, it can also identify the metabolite separately.
"Willkomm, the current CEO, said the company will spend much of 2016 perfecting a portable test for THC"
"SpinDx can run multiple assays in a minute from a single drop of blood or other bodily fluid, making it a great fit in Lifeloc Technologies’ work in helping to detect drug abuse"
"Feasibility of detection has already been demonstrated for very low levels of delta-9-THC, cocaine, and methamphetamine."
I remind you that with any type of positive news announcement on the marijuana breathalyzer, we should see an absolute explosive move higher.
The marijuana breathalyzer and cannabis safety industry is about to go from 0 to $10 Billion and I have to remind the board that there is only so much stock that can go around here.
The best part about investing in this company is that it doesn't matter which side of the fence you're on, for or against marijuana - both sides see the need for keeping impaired drivers off the road - and impaired workers off the job site. Along with legalization comes accountability.
they have an established market and customer base. To add to this, they have a broad product line of other drug and alcohol testing and training products - something the government wants. They are already profitable, own the building which houses almost 40 employees, have money in the bank - so no need for dilutive financing.
I still think with a float this small and a sector that will be hot for the foreseeable future, we have a good shot at seeing something nutty happen in this stock.
Marijuana/cannabis names have recently shown they can move 3,000%, 5,000%, 7,500%. etc with a much bigger float and market cap than LCTC.
Drug screening products:
We offer a full line of drugs of abuse (DOA) testing products including saliva tests, collection cups, test cups, dip cards, adulteration strips, bluing tablets and other testing supplies.
Marijuana and the workplace online drug training course
Cannabis impairment goggles
Drug and alcohol policy guidance
Substance abuse professionals
Drug and alcohol employee awareness course
"One of the biggest areas these new laws focus on is impaired driving."
"The need for some sort of testing devices is only getting bigger."
"There's no projections right now for how big the marijuana breathalyzer market will be. But with close to 18,000 U.S. state and local law enforcement agencies as of July 2016, the market is huge."
The new federal provisions mandating additional study on marijuana and driving are part of a $305 billion highway funding bill that President Obama signed on December 4.
Let's be conservative here and say 2% of this highway funding bill will go towards this government review on methods for detecting marijuana-impaired driving and keeping our roads safe. 2% of $305 Billion gives us $6.1 Billion to work with. Let's now say that Lifeloc is able to capture just 2% of this funding amount. We get a figure of $122 million.
I can not think of a more well positioned company in the public space that is a better fit for a portion of this funding:
The global market for breath analyzers is a market expected to grow to over $4.5 billion in the coming years. Lifeloc technologies is only currently capturing less than a ¼ of 1% of this market and they are listed as a key player in the space along with Alcohol Countermeasure Systems (International), Inc., Ekips Technologies, Inc., Dragerwerk AG & Co. KGaA, Intoximeters, Inc., Alcolizer Pty. Ltd. Quest Products, Inc, MPD, Inc., and PAS Systems International.
If LCTC can capture a mere 2 ½ % of this market share, I would expect it to have a market cap of at least $100 million and be trading above $40/share.
Of the 230 or so total marijuana publicly traded companies, LCTC was proven to have the smallest public float (by far), the sixth highest cash position, and the second highest revenue figures.
